Last reviewed · How we verify

NCT06014151: DONDON2

Motivations and Psychological Aspects of Gamete Donation

Status unknown Last updated 28 August 2023
What this trial tests

trial testing questionnaires in GERM CELLS in 1,000 participants. Status unknown.

Timeline
31 July 2023
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date31 July 2023
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with GERM CELLS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this project is to describe the motivations, the representation of donation and sterility, to evaluate the psychological aspects of the new male and female candidates to gamete donation and then to compare the results obtained from this population (post anonymity) with the previous population (anonymity).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionnaires

Trials testing the same drug.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06014151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing